Related content

Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer

By Aurilio Gaetano   Monfardini Lorenzo   Rizzo Stefania   Sciandivasci Angela   Preda Lorenzo   Bagnardi Vincenzo   Disalvatore Davide   Pruneri Giancarlo   Munzone Elisabetta   Della Vigna Paolo   Renne Giuseppe   Bellomi Massimo   Curigliano Giuseppe   Goldhirsch Aron   Nolè Franco  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1649-1656

Informa Healthcare

Access to resources Recommend Favorite

Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis

By Vrieling Alina   Buck Katharina   Kaaks Rudolf   Chang-Claude Jenny  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 641-649

Springer Publishing Company

Access to resources Recommend Favorite

Oestrogen and progesterone receptor status of individual foci in multifocal invasive ductal breast cancer

By Garimella V.   Long E. D.   O'Kane S. L.   Drew P. J.   Cawkwell L.  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 204-207

Informa Healthcare

Access to resources Recommend Favorite

Prognostic impact of progesterone receptor status combined with body mass index in breast cancer patients treated with adjuvant aromatase inhibitor

By              

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 3286-3292

Spandidos Publications

Access to resources Recommend Favorite

miR-155 and miR-31 are differentially expressed in breast cancer patients and are correlated with the estrogen receptor and progesterone receptor status

By            

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 1027-1032

Spandidos Publications

Access to resources Recommend Favorite